In FUS-mutated ALS, the primary driver of pathogenicity is thought to be the impaired nuclear localization of FUS protein, with a downstream of pathophysiological mechanisms and FUS protein’s toxic gain of function effect [156]. This evidence concerns the gene FUS and amyotrophic lateral sclerosis.